CONTEXT: Although the technical feasibility of laparoscopic donor nephrectomy (LDN) has been established, concerns have been raised about the impaired renal function resulting from pneumoperitoneum and its short- and long-term effects. AIMS: We used urinary biomarkers of acute kidney injury including urinary neutrophil gelatinase-associated lipocalin (uNGAL) and urinary N-acetyl-beta-D-glucosaminidase (uNAG) to study the injury caused to the donor's retained kidney by pneumoperitoneum. SETTINGS AND DESIGN: This was a prospective cohort study of thirty consecutive patients who underwent LDN at our hospital. SUBJECTS AND METHODS: We measured urinary creatinine, uNAG and uNGAL at the time of induction of anaesthesia, at 1 h after starting surgery, at 5 min after clamping the ureter, at the time of skin closure and then at 4, 8 and 24 h after the surgery. RESULTS: The uNAG level showed a gradual increase from the start of the surgery and reached the peak at the time of the closure. Thereafter, there was a gradual fall in the level and reached to pre-operative level at 24 h post-surgery. Similarly, the uNGAL also showed a similar trend although it did not reach pre-operative value by 24 h. CONCLUSIONS: We objectively confirm that although there is acute injury to the retained kidney in the donor after LDN due to the CO2pneumoperitoneum, the renal function improves and reaches close to the pre-operative level within 24 h after surgery.
CONTEXT: Although the technical feasibility of laparoscopic donor nephrectomy (LDN) has been established, concerns have been raised about the impaired renal function resulting from pneumoperitoneum and its short- and long-term effects. AIMS: We used urinary biomarkers of acute kidney injury including urinary neutrophil gelatinase-associated lipocalin (uNGAL) and urinary N-acetyl-beta-D-glucosaminidase (uNAG) to study the injury caused to the donor's retained kidney by pneumoperitoneum. SETTINGS AND DESIGN: This was a prospective cohort study of thirty consecutive patients who underwent LDN at our hospital. SUBJECTS AND METHODS: We measured urinary creatinine, uNAG and uNGAL at the time of induction of anaesthesia, at 1 h after starting surgery, at 5 min after clamping the ureter, at the time of skin closure and then at 4, 8 and 24 h after the surgery. RESULTS: The uNAG level showed a gradual increase from the start of the surgery and reached the peak at the time of the closure. Thereafter, there was a gradual fall in the level and reached to pre-operative level at 24 h post-surgery. Similarly, the uNGAL also showed a similar trend although it did not reach pre-operative value by 24 h. CONCLUSIONS: We objectively confirm that although there is acute injury to the retained kidney in the donor after LDN due to the CO2pneumoperitoneum, the renal function improves and reaches close to the pre-operative level within 24 h after surgery.
Laparoscopic donor nephrectomy (LDN) is increasingly performed nowadays in many centres. Although the technical feasibility of LDN has been established, concerns have been raised about the impaired renal function resulting from pneumoperitoneum and its short- and long-term effects both in the recipient.[12] Although animal studies have shown that abdominal gas insufflation does not impair renal function in the donor 1 year after LDN, there is scarcity in the literature supporting these findings in human studies.[3] At present, serum creatinine, which is used to measure the glomerular filtration rate (GFR), is the most commonly used marker of renal function post-surgery. Unfortunately, serum creatinine is a delayed and unreliable indicator of acute kidney injury (AKI) as it is influenced by multiple non-renal factors, such as muscle mass, muscle metabolism, diet, medications and hydration status. Moreover, the serum creatinine level can take several hours or days to reach a new steady state and thus does not reflect the actual decrease in GFR in the acute setting as evidenced by the fact that it lags behind structural changes that occur in the kidney during the early stage of AKI. Several studies have shown that urinary markers such as urinary neutrophil gelatinase-associated lipocalin (uNGAL) and urinary N-acetyl-beta-D-glucosaminidase (uNAG) are both sensitive and specific in identifying the AKI in various situations including in shock, post-cardiac surgery.[45] The aim of this study is to understand if LDN has any effect on the long-term renal function in the other renal unit in the donor. We used urinary markers as surrogate indicators for ascertaining injury caused to the donor's kidney by the pneumoperitoneum and its long-term effects.
SUBJECTS AND METHODS
Study design
This was a prospective cohort study of thirty consecutive patients who underwent LDN between April 2013 and September 2013 at our hospital which is a tertiary care centre for urology where we so far have done 2615 renal transplants and 1205 LDN. Patients with body mass index (BMI) >30 kg/m2, diabetes mellitus, severe atherosclerosis, asthma or chronic bronchitis, inflammatory bowel disease, hepatitis, hyperlipidaemia, alcohol ingestion and malignancy (lung, colorectal, breast, pancreas, leukaemia) were excluded from the study. The pre-operative parameters studied included estimated GFR (eGFR), haemoglobin, serum creatinine, urine routine and culture, urinary creatinine (uCr), uNAG and uNGAL. All participants consented to the study. The Institutional Review Board of our hospital approved the study protocol. Pre-operative computed tomography angiography was done in all the donors to assess the vascular anatomy. The kidney which was to be grafted was decided on the pre-operative assessment of the GFR and the vascular anatomy. LDN was done by one of the four urosurgeons with advanced laparoscopic training. All the donors were given adequate hydration intra-operatively and post-operatively.
Data collection
Medical records of study participants were reviewed prospectively to retrieve hospitalisation data, including baseline demographic characteristics; coexisting conditions and pre-operative renal variables including eGFR as measured by modification of diet in renal disease (MDRD) formula, haemoglobin, serum creatinine, urine routine and culture, uCr, uNAG and uNGAL. Then, urine NAG, NGAL, urine creatinine were measured before the start of surgery (at the induction of anaesthesia), at 1 h after starting surgery, at 5 min after clamping the ureter (this urine is mainly from the other retained kidney in the donor), at the end of the surgery (at the time of skin closure), 4, 8 and 24 h after the surgery. The time of surgery and the side of nephrectomy were also noted. Post-operative parameters also included serum creatinine at 24 h, 30 days, 3 months and 1 year after surgery.
Measurement of urinary neutrophil gelatinase-associated lipocalin, urinary N-acetyl-beta-D-glucosaminidase and creatinine levels
The uNGAL level was measured by ELISA test using the kit manufactured by BioPorto® Diagnostics, Denmark (Category No. Kit 037). The uNAG was measured by colorimetric method using 4-nitrophenyl-glycoside substrates. The uCr was measured in Fully Automated Biochemistry Analyser CX5® PRO, Beckman Coulter, using the kit purchased from Beckman.In this study, uNAG activity and uNGAL level were normalised to the uCr level to account for the difference in the relative amount of water extracted along the nephron. The various parameters were measured as mean with standard deviation and were studied by trend analysis.
RESULTS
A total of 30 consecutive donors undergoing consecutive nephrectomies were studied, out of which 5 patients were male and 25 patients were female. The mean age of the patients was 48.51 ± 10.15 years. The mean BMI, mean pre-operative serum creatinine and mean eGFR were 23.4 ± 3.56 kg/m2, 0.63 ± 0.13 mg/dl and 107.24 ± 23.56 ml/min (MDRD formula), respectively. The mean time duration of the surgery and pneumoperitoneum were 157 ± 24.7 min and 145.6 ± 26.75 min, respectively [Table 1]. Three patients had post-operative fever (Clavien-Dindo Grade 1) which settled with conservative measures and one patient had post-operative chylous ascites which required laparoscopic clipping of the lymphatics (Clavien-Dindo Grade 3b).
Table 1
Demography of the donors
Demography of the donorsThe uNAG level normalised to the uCr showed a gradual increase from the start of the surgery (4.63 ± 4.64 IU/mg at the induction and 24.47 ± 11.86 IU/mg at 1 h after starting surgery) and reached the peak (40.86 ± 19.69 IU/mg) at the completion of the surgery. Thereafter, there was a gradual fall in the level (26.79 ± 19.14 IU/mg and 9.45 ± 6.57 IU/mg at 4 h and 8 h after surgery, respectively) and reached close to pre-operative level (6.07 ± 5.15 IU/mg) at 24 h post-surgery [Figure 1]. Similarly, the uNGAL level when normalised to urine creatinine showed a similar trend with gradual increase from the start (84.07 ± 127.83 IU/mg at the induction of surgery and 95.36 ± 102.52 IU/mg at 1 h after starting surgery), reaching peak level at the completion of the surgery (247.04 ± 163.83 IU/mg) after which there was a downward trend (196.59 ± 139.04 IU/mg and 113.15 ± 111.98 IU/mg at 4 h and 8 h after surgery, respectively) although it did not reach pre-operative value by 24 h (110.25 ± 173.44 IU/mg) [Table 2]. There was no correlation made between the operative/pneumoperitoneum time and the level of these markers.
Figure 1
Graphical representation of the values of urinary creatinine, urinary neutrophil gelatinase-associated lipocalin and urinary N-acetyl-beta-D-glucosaminidase
Table 2
Depicting the values of urinary N-acetyl-beta-Dglucosaminidase, urinary neutrophil gelatinase-associated lipocalin and urine creatinine
Graphical representation of the values of urinary creatinine, urinary neutrophil gelatinase-associated lipocalin and urinary N-acetyl-beta-D-glucosaminidaseDepicting the values of urinary N-acetyl-beta-Dglucosaminidase, urinary neutrophil gelatinase-associated lipocalin and urine creatinineThe mean post-operative serum creatinine at 24 h post-surgery was 0.91 ± 0.30 mg/dl, which improved to 0.86 ± 0.79 mg/dl at 1 month post-surgery and 0.81 ± 0.14 mg/dl at 3 months and 0.76 ± 0.23 mg/dl at 1 year after surgery [Table 3].
Table 3
Mean serum creatinine trend post surgery
Mean serum creatinine trend post surgery
DISCUSSION
There are several concerns with the application of the laparoscopic approach for live renal donation. As it involves a healthy individual who is subjected to a major surgery to benefit another individual, safety of the donor is the first priority. Further, the kidney which is procured laparoscopically should provide excellent recipient graft outcomes. Since the initial report by Ratner et al.[6] in 1995, LDN has become the standard technique in many transplant centres worldwide in view of the inherent advantages of laparoscopy including less post-operative pain, better cosmesis and shorter convalescence, which will increase the number of kidney donations.[7] However, laparoscopic procurement has other inherent problems including mechanical injury to the graft, longer warm ischaemia time and pneumoperitoneum, which may cause the primary dysfunction of transplanted kidneys.[8] Although stable long-term graft function was demonstrated in retrospective studies at 1 year post-transplant in both open donor nephrectomy and LDN, it has been shown that recipients of laparoscopically procured kidneys have higher serum creatinine levels and a greater need for dialysis in the 1st weeks after transplantation.[8910] It has been shown that pneumoperitoneum causes increased intra-abdominal pressure which compresses the renal parenchyma and renal vein and can cause transient renal dysfunction due to impaired renal blood flow.[11112] However, there is scarcity in literature regarding the effect of pneumoperitoneum on the retained kidney in the donor. As serum creatinine is a delayed and unreliable indicator of AKI in the post-operative setting, we studied the effect of pneumoperitoneum on the donor renal function using non-invasive markers of renal ischaemia including uNGAL and uNAG.NGAL is a protein which is covalently bound to gelatinase and is mainly secreted from neutrophils and epithelial cells. It is concerned with the regulation of the tissue rebuilding mainly in the angiogenesis. Various organs which contain epithelial tissue including the kidneys produce a small amount of NGAL. However, its expression is rapidly increased in conditions that cause AKI when it can be detected in both the plasma and urine. It rises by 10-fold within only 3 h. After renal ischaemia, it has been found that there is rapid and massive induction of NGAL in renal tubular cells.[13] Many other conditions including post-cardiac surgery, contrast-induced nephropathy, diabetic nephropathy and transplant rejection were also found to induce rapid increase in plasma NGAL (pNGAL) and uNGAL. Studies have also shown that uNGAL is probably more reflective for evaluation of the local renal injury than pNGAL[14] and its increase in AKI precedes that of creatinine by 1–3 days and thus represents an early predictive biomarker for the development of AKI.[15] Thus, uNGAL represents a sensitive non-invasive marker of renal ischaemia.Wellwood et al. described the utility of uNAG activity as a marker of acute or chronic kidney injury more than 30 years ago.[16] Then, in subsequent years, its role was limited to detect mild, sub-clinical renal tubular injury.[1718] More recently, it has been confirmed that increased excretion of uNAG was shown to be of diagnostic value for the early detection of AKI.[1819] NAG is mostly produced in proximal tubular epithelial cell lysosomes, and an increase in its urinary activity is a sensitive and reasonably specific measure of renal tubular damage, because it has a relatively large molecular weight (>130 kD) which precludes its filtration by the glomerulus. It has been found in studies that in patients with established acute renal failure, uNAG activity is a useful surrogate marker for the severity of AKI and also has a prognostic utility similar to or better than conventionally used severity markers including urine output and serum creatinine level.[20] uNAG activity remains elevated during active renal disease.In animal studies done by Hazebroek et al.[3] in rats, it has been found that abdominal gas insufflation did not impair renal function in the donor, 1 year after LDN, and there was no difference found in renal function or histomorphology between kidney grafts exposed to either pneumoperitoneum or gasless procedure.The uNGAL and the uNAG measured at the start of the surgery and after 1 h signify the urine from both the kidneys, and there was increase in both the levels which indicate that there is acute tubular injury to both the kidneys. The third sample measured at 5 min after the ureteric clamping indicated the urine from the retained kidney in the donor and interestingly both the urinary markers increased exponentially and reached the peak at the sample taken at the end of the surgery suggesting that there is considerable injury caused to the donor retained kidney by the pneumoperitoneum. We could not find any correlation between the operative time and the level of these markers. However, the levels of both the biomarkers started to decrease thereafter suggesting that this effect is only transient and the levels almost but not completely reached to pre-operative levels by 24 h. Thus, the LDN, although causes a transient renal ischaemic injury, is safe in the long run and is advantageous for the donor in terms of residual renal function and decreased pain and early convalescence. The limitation of this study is that we had a small study group (30 donors) with short follow-up. Although uNGAL is a very sensitive marker for AKI, uNAG has less specificity for AKI which has been viewed as another shortcoming of the study. Further prospective trials are required with larger numbers in the future.
CONCLUSIONS
In this study, we found that although there is acute injury to the retained kidney in the donor after LDN due to the CO2 pneumoperitoneum, the renal function improves and reaches close to the pre-operative level within 24 h after surgery. Thus, LDN done by experts in high volume centres is safe to the donors in the long-term.
Authors: J M Nogueira; C B Cangro; J C Fink; E Schweitzer; A Wiland; D K Klassen; J Gardner; J Flowers; S Jacobs; E Cho; B Philosophe; S T Bartlett; M R Weir Journal: Transplantation Date: 1999-03-15 Impact factor: 4.939
Authors: L E Ratner; R A Montgomery; W R Maley; C Cohen; J Burdick; K D Chavin; D S Kittur; P Colombani; A Klein; E S Kraus; L R Kavoussi Journal: Transplantation Date: 2000-06-15 Impact factor: 4.939
Authors: Philipp Kümpers; Carsten Hafer; Alexander Lukasz; Ralf Lichtinghagen; Korbinian Brand; Danilo Fliser; Robert Faulhaber-Walter; Jan T Kielstein Journal: Crit Care Date: 2010-02-01 Impact factor: 9.097
Authors: H K Kang; D K Kim; B H Lee; A S Om; J H Hong; H C Koh; C H Lee; I C Shin; J S Kang Journal: J Korean Med Sci Date: 2001-10 Impact factor: 2.153
Authors: Nicole M Shockcor; Sam Sultan; Josue Alvarez-Casas; Philip S Brazio; Michael Phelan; John C LaMattina; Rolf N Barth Journal: Langenbecks Arch Surg Date: 2018-08-21 Impact factor: 3.445